Sign In
Get Clay Free →

Suggestions

    Michelle Drozd

    Executive Director Reimbursement Policy at Gilead Sciences

    Professional Background

    Michelle Drozd is a seasoned health policy professional with a broad spectrum of experience in the biopharmaceutical industry, healthcare payment and delivery system reform, quality improvement, and health information technology. With a career spanning multiple influential positions in leading organizations, Michelle has established herself as a thought leader in the realm of health policy, making substantial contributions to shaping effective strategies for patient care and healthcare reform.

    Currently serving as the Executive Director of Reimbursement Policy at Gilead Sciences, Michelle leverages her extensive knowledge to navigate complex policy landscapes and advocate for innovative healthcare solutions. Her work emphasizes the importance of fair reimbursement practices and the pivotal role they play in ensuring access to critical biopharmaceuticals for patients in need.

    Prior to her current role, Michelle held several key positions within the Pharmaceutical Research and Manufacturers of America (PhRMA), where she worked tirelessly to promote policies that encourage pharmaceutical innovation and ensure that patients can access necessary medications. As Deputy Vice President and Senior Director of Policy and Research, she played a vital role in shaping the organization’s advocacy strategies and research initiatives, laying the groundwork for transformative health policies.

    Michelle’s career commenced at Partners HealthCare, where she diversified her expertise through various roles, including Consultant for the High Risk Patient Strategy Project, Program Director for Disease Management and Clinical Resource Management Teams, and Project Manager for Business Planning. This tenure provided her with practical insights into the intricacies of healthcare delivery systems and the importance of strategic resource management.

    Early in her career, she gathered valuable analytical experience as a Research Analyst at RTI International, where she honed her skills in data analysis and research methodologies.

    Education and Achievements

    Michelle’s academic foundation is rooted in a robust education, having earned her ScM from the esteemed Harvard T.H. Chan School of Public Health. Her rigorous training in public health has equipped her with a profound understanding of health systems, policy development, and the critical factors influencing public health initiatives. Additionally, her undergraduate studies at Duke University further contributed to her expertise in health policy and management, laying the groundwork for her remarkable career.

    Notably, Michelle’s contributions to health policy are recognized through her involvement in significant initiatives and strategic projects aimed at reforming the healthcare landscape. Her work has impacted various sectors within healthcare, driving quality improvement and enhancing health information technology.

    Achievements

    Michelle Drozd’s career is decorated with numerous achievements that underscore her dedication to health policy excellence. Through her leadership roles, she has successfully influenced policy discussions and initiatives at critical intersections of healthcare delivery and pharmaceutical innovation. Her commitment to improving healthcare access and quality has led her to develop and implement policies that serve both patients and the broader healthcare community.

    Her work with Gilead Sciences focuses on promoting reimbursement strategies that enhance patient access to therapeutic innovations, showcasing her unwavering dedication to addressing the needs of high-risk populations. Through her roles at PhRMA, she has been instrumental in fostering collaborative relationships between pharmaceutical developers and healthcare stakeholders, promoting a unified approach to healthcare reform.

    Moreover, Michelle's role at Partners HealthCare highlights her expertise in utilizing data-driven strategies to enhance patient care and resource management, reflecting her comprehensive understanding of the healthcare delivery system. Her early experience at RTI International solidified her research and analytical skills, allowing her to drive evidence-based policy recommendations effectively.

    With her impressive background, Michelle Drozd continues to be a formidable force in the health policy arena, advocating for progressive health reforms and ushering in improved quality of care for patients across the globe.

    Related Questions

    How did Michelle Drozd develop her expertise in health policy and the biopharmaceutical industry?
    What are some of the key initiatives Michelle Drozd has contributed to at Gilead Sciences?
    How has Michelle Drozd's education at Harvard T.H. Chan School of Public Health influenced her career in health policy?
    What challenges has Michelle Drozd faced in her roles within healthcare delivery systems?
    How does Michelle Drozd approach quality improvement in healthcare settings?
    Michelle Drozd
    Add to my network

    Location

    Silver Spring, Maryland, United States